In the medical field, anti-bacterial drugs are a “strong weapon” against bacterial infections, but in order to ensure that their use is safe and effective, we have introduced a hierarchy of anti-bacterial drugs.
Details of this and their use are given below. Antibacterial drugs are managed on a hierarchical basis. Antibacterial drugs are divided into three levels: non-restrictive, restricted and special. Non-restricted use of a class-of-prescribed antibacterial drug means a relatively low-priced antibacterial drug proven to be safe and effective by long-term clinical application, with a low impact on bacterial resistance.
Like our common Amoxilin capsule, it is used clinically to treat a number of common mild bacterial infections, such as mild respiratory infections, urinary system infections, etc.
In general, medical practitioners at all levels of health care can issue such drugs on the basis of a medical diagnosis, which is easier and more common. Restrictions on the use of class-based antibacterial drugs are recognized as relatively safe and effective, but there are limitations in some areas, such as therapeutic efficacy, safety, effects on bacterial resistance, and drug prices.
Such drugs require a physician with the title of primary care and above to be prescribed. For example, PFPs, when faced with moderate bacterial infections, such as community access to sexually transmitted pneumonia, the attending physician, after assessing the condition, considers it appropriate to use it for treatment, and it is more prudent to use it in comparison to the non-restricted level of use.
Specially used antibacterial drugs are antibacterial drugs that have a clear or severe adverse effect and are not suitable for random use; either antibacterial drugs that are more antibacterial, have a wide spectrum of antibacterial resistance, and are frequently or overused, which can lead to rapid bacterial resistance; or antibacterial drugs that have less clinical information on efficacy, safety and are expensive. Like Vancomycin, a “cecetal” for drug-resistant bacteria, it is generally used in cases where the patient is infected with very serious drug-resistant strains, such as blood flow infections caused by methoxylincin-coloured fungus (MRSA), after an expert consultation, with prescriptions issued by a physician with advanced technical qualifications, and more closely monitoring the patient’s indicators. I have encountered a case in which an old man was hospitalized for lung infections, initially treated by doctors on the basis of his condition with non-restricted antibacterial drugs, and observed that infection control was not ideal for days.
After further examination and assessment, the attending physician assessed the condition to be more moderately infected, replacing it with a limited use of antibacterial drugs for further treatment, which later gradually improved. This reflects the importance of stratification and rational choice of different levels of antibacterial drugs based on the condition. The correct use of antibacterials, regardless of the level of antibacterials, must first be clearly diagnosed with bacterial infection. Since in many cases diseases such as flu are mostly virus-induced, the use of antibacterial drugs is not only ineffective but can also lead to adverse reactions and increased risk of bacterial resistance. Antibacterial drugs are used strictly at the prescribed doses, frequency and course of treatment.
It is not possible to feel self-determinating when symptoms are reduced, which can easily result in bacteria not being completely eliminated, leading to repeated cases and even to bacteria producing resistance. For example, some patients who took the Achicillin to treat secondary infections, who took two or three days and felt better like coughing, stopped their medications, and soon again, the effect of the drug was reduced.
At the same time, in the course of drug use, care is taken to see whether there have been adverse reactions, such as rashes, nausea, diarrhoea, etc. In the event of an anomaly, the doctor should be informed in a timely manner so that he may determine whether to continue with the drug, adjust the drug or take appropriate treatment.
In short, the hierarchical management of antibacterial drugs is for the scientific and rational use of these drugs, and we have the right way of using them, both to protect our own health and to reduce the incidence of adverse conditions such as bacterial resistance and to make antibacterial drugs work better.
